get a key
steadybase-$ company TCMD
account_id none on file
legal_name Tactile Systems Technology Inc
ticker TCMD
cik 1027838
domain tactilemedical.com
entry_point_account_id none on file
name Tactile Systems Technology Inc.
exchange Nasdaq
sector Health Care
hq Minneapolis, MN, United States
calls 9 filings 40 executives 8 family 0
why_nownone on file
calls
For these patients, the constant swelling and discomfort of the breast, trunk, arms, and hands limits mobility, activity, and travel.

Nov 4, 2024 / receipt, needs a key / Sherry Dodd, CEO | earnings call 2024-11-04 | transcript 07ce6b8e-c5ee-49e1-a279-c15e4fd90870 | chars 16816-16949 | segment 16

The increase in operating expenses year over year was primarily driven by a $2.3 million increase in sales and marketing expenses due to new hires added to our Lymphedema sales team, along with increased travel-related expenses as we return to normalized business activities.

Feb 21, 2023 / receipt, needs a key / Brent Moen, CFO | earnings call 2023-02-21 | transcript b350df0c-36e8-49e6-a0be-b47ccf499deb | chars 17520-17795 | segment 16

The increase in operating expenses year over year was primarily driven by a $4.4 million increase in sales and marketing expenses, largely due to the addition of our AfloVest sales team and new hires added to our Lymphedema sales team, along with increased travel and related expenses as we return to normalized business activities.

Nov 7, 2022 / receipt, needs a key / Brent Moen, CFO | earnings call 2022-11-07 | transcript c2dba02a-ac61-4261-841d-4dc7cbbc70b4 | chars 15507-15839 | segment 15

The increase in operating expenses year-over-year was primarily driven by a $7.9 million increase in sales and marketing expenses, largely due to the addition of our AfloVest sales team and new hires added to our Lymphedema sales team, along with increased travel-related expenses as we return to normalized business activities, expenses related to our in-person national sales meeting held in April, and costs associated with new product introductions.

Aug 1, 2022 / receipt, needs a key / Brent Mullen, CFO | earnings call 2022-08-01 | transcript 585282ab-0c01-4640-9c12-61c92b62f036 | chars 13860-14313 | segment 14

The increase in operating expenses was also driven by a $5.1 million increase in sales and marketing expenses, largely due to increases in personnel-related compensation expense, including the addition of the AfloVest-related commercial expenses and travel-related expenses as we return to normalized business activities.

May 2, 2022 / receipt, needs a key / Brent, other | earnings call 2022-05-02 | transcript efcfd67f-a7fe-4a86-af25-2bafeef00d10 | chars 12607-12928 | segment 12

The increase in operating expenses was driven primarily by a $5 million, or 26 percent, increase in sales and marketing expenses, largely due to increases in personnel-related compensation expense, including the addition of the AfloVest sales team, and travel-related expenses as we return to hosting in-person regional sales meetings.

Feb 22, 2022 / receipt, needs a key / Brent Moen, CFO | earnings call 2022-02-22 | transcript c12ca097-9652-46ac-8156-3decfca45987 | chars 9964-10299 | segment 10

The year-over-year increase in operating expenses was driven primarily by a $2.7 million, or 14%, increase in sales and marketing expenses primarily due to increases in personnel-related compensation expense and travel-related expenses as we return to hosting in-person regional sales meetings.

Nov 8, 2021 / receipt, needs a key / Brent Moen, CFO | earnings call 2021-11-08 | transcript cb775128-5d95-424b-b1cc-8c38902b1073 | chars 13526-13820 | segment 13

The decrease in sales and marketing expenses was driven by virtual sales meetings, along with lower patient training costs, and reduced T&E.

May 3, 2021 / receipt, needs a key / Brent, CFO | earnings call 2021-05-03 | transcript 0f6b108e-c470-4ac9-8328-54b7b171e978 | chars 13330-13470 | segment 13

The decrease was driven by lower patient training costs, sales commissions, and travel and entertainment expenses.

Feb 23, 2021 / receipt, needs a key / Brent, CEO | earnings call 2021-02-23 | transcript e2e34a67-80f9-4f70-b88c-5ae946fb2a92 | chars 12739-12853 | segment 13

filings
Senior Manager, Field Marketing | {"ats": "greenhouse", "city": "Atlanta, Georgia; Charlotte, North Carolina; Chicago, Illinois; Dallas, Texas; Denver, Colorado; Minneapolis, Minnesota; Phoenix", "sta

company_statement / Sep 15, 2026 / receipt

Patient Education Consultant | {"ats": "greenhouse", "city": "Clarion", "state": "PA", "job_id": "4402294009", "remote": false, "category": "other", "function": "clinical", "location": "Clarion, Penns

company_statement / Sep 15, 2026 / receipt

Principal Regulatory Specialist | {"ats": "greenhouse", "city": "New Brighton", "state": "MN", "job_id": "4392288009", "remote": false, "category": "other", "function": "legal", "location": "New Brigh

company_statement / Sep 11, 2026 / receipt

Senior R&D Engineer | {"ats": "greenhouse", "city": "New Brighton", "state": "MN", "job_id": "4373710009", "remote": false, "category": "other", "function": "engineering", "location": "New Brighton, M

company_statement / Sep 10, 2026 / receipt

Cash Management Analyst | {"ats": "greenhouse", "city": "Minneapolis", "state": "MN", "job_id": "4377611009", "remote": false, "category": "other", "function": "other", "location": "Minneapolis, Minne

company_statement / Sep 10, 2026 / receipt

Reimbursement Specialist | {"ats": "greenhouse", "city": "Minneapolis", "state": "MN", "job_id": "4391076009", "remote": false, "category": "other", "function": "other", "location": "Minneapolis, Minn

company_statement / Sep 10, 2026 / receipt

Medical Device Sales Associate Territory Account Manager | {"ats": "greenhouse", "city": "Burlington", "state": "VT", "job_id": "4395973009", "remote": false, "category": "sales_expansion", "function"

company_statement / Sep 10, 2026 / receipt

Financial Services Representative | {"ats": "greenhouse", "city": "Minneapolis", "state": "MN", "job_id": "4391114009", "remote": false, "category": "finance_ops", "function": "other", "location": "Mi

company_statement / Sep 9, 2026 / receipt

Patient Advocate | {"ats": "greenhouse", "city": "Minneapolis", "state": "MN", "job_id": "4391758009", "remote": false, "category": "other", "function": "clinical", "location": "Minneapolis, Minnesota

company_statement / Sep 9, 2026 / receipt

Medical Device Sales Territory Account Manager | {"ats": "greenhouse", "city": "Kansas City, Kansas; Overland Park", "state": "KS", "job_id": "4396479009", "remote": false, "category": "sales_expansio

company_statement / Sep 9, 2026 / receipt

Group Marketing Manager, Product Portfolio | {"ats": "greenhouse", "city": "Minneapolis", "state": "MN", "job_id": "4259105009", "remote": false, "category": "other", "function": "marketing", "locatio

company_statement / Sep 8, 2026 / receipt

Medical Device Sales Associate Territory Account Manager | {"ats": "greenhouse", "city": "Phoenix", "state": "AZ", "job_id": "4387410009", "remote": false, "category": "sales_expansion", "function": "

company_statement / Sep 8, 2026 / receipt

executives
Brent Moen CFO - receipt
Brent Mullen CFO - receipt
Dan Reavers CEO - receipt
Dan Revers CEO - receipt
Elaine M. Birkemeyer Chief Financial Officer - receipt
Eric Pauls Senior Vice President - receipt
Sheri L. Dodd Chief Executive Officer - receipt
Sherry Dodd CEO - receipt
familynone on file
upcoming
2026-11-02 earnings call scheduled ir
changes
2024-04-23 Chief Executive Officer, appointed sec_8k
2023-03-14 Chief Financial Officer, appointed sec_8k
2021-04-20 Senior Vice President, appointed sec_8k
2018-03-09 director, departed sec_8k
mcp_package_hint
steadybase-$